Revised Schedule M 2025: What Pharma Companies Need to Know
The Revised Schedule M 2025 marks a significant update in India’s drug regulation framework. Announced in mid‑2025, these reforms are designed to strengthen Good Manufacturing Practices (GMP), align domestic protocols with global standards, and elevate the safety and quality of pharmaceutical products. For more information contact us today on +91-7815407225 or Email us jvhealthcare0123@gmail.com . Key Changes Under the New Schedule M India 2025 1. Enhanced Facility Standards o Mandatory modernization of facility infrastructure, covering HVAC, clean rooms, and controlled environments. o Updated building and layout requirements to prevent cross-contamination and ensure product integrity. 2. Stringent Quality Control Systems o Implementation of updated in-process controls and standardized validation of equipment. o Requirements for advanced analytical labs equ...